ArticleBMC ophthalmology2025
Central Retinal Vein Occlusion (CRVO) complicating post-cataract surgery: a case report and multifactorial analysis.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCentral retinal vein occlusion (CRVO) is a rare but severe complication following cataract surgery. This report highlights a unique case of CRVO secondary to phacoemulsification in a patient with multiple comorbidities. CASE PRESENTATION: A 60-year-old female presented with left-eye blurred vision, photophobia, and elevated intraocular pressure. Preoperative findings included neovascular glaucoma, nuclear cataract, and suspected retinitis pigmentosa. Postoperatively, she developed CRVO with flame-shaped retinal hemorrhages, confirmed via fundoscopy and optical coherence tomography (OCT). Laboratory tests revealed hypertriglyceridemia (3× normal).
conclusionThis case underscores the synergistic roles of vascular pathology (neovascular glaucoma), surgical stress (IOP fluctuations), and metabolic dysfunction (hypertriglyceridemia) in CRVO pathogenesis. Perioperative monitoring of blood rheology and targeted interventions (e.g., anti-VEGF therapy) may mitigate risks in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.